Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$912M |
| 2 |
Pinduoduo
PDD
|
+$727M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$584M |
| 4 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$501M |
| 5 |
GE Aerospace
GE
|
+$434M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.45B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.3B |
| 3 |
Apple
AAPL
|
+$1.26B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$795M |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$650M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.48% |
| 2 | Financials | 8.47% |
| 3 | Consumer Discretionary | 7.62% |
| 4 | Healthcare | 7.22% |
| 5 | Industrials | 5.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5076
Ovid Therapeutics
OVID
$489M
| $180K | ﹤0.01% |
58,984
-2,811
| -5% | -$9.41K |
|
5077
EverCommerce
EVCM
$2.1B
| $179K | ﹤0.01% |
19,036
+1,909
| +11% | +$18.6K |
|
5078
Riverview Bancorp
RVSB
$109M
| $178K | ﹤0.01% |
37,615
+50
| +0.1% | +$260 |
|
5079
CorMedix
CRMD
$581M
| $177K | ﹤0.01% |
41,713
+4,663
| +13% | +$16.2K |
|
5080
OptimizeRx
OPRX
$130M
| $176K | ﹤0.01% |
14,470
+1,104
| +8% | +$16K |
|
|
RPTX
5081
DELISTED
Repare Therapeutics
RPTX
| $171K | ﹤0.01% |
36,287
+7,349
| +25% | +$47.1K |
|
5082
Caesarstone
CSTE
$80.2M
| $171K | ﹤0.01% |
41,755
-19,005
| -31% | -$77.8K |
|
|
ADAP
5083
DELISTED
Adaptimmune Therapeutics
ADAP
| $170K | ﹤0.01% |
107,562
+91,583
| +573% | +$111K |
|
5084
Atara Biotherapeutics
ATRA
$76.9M
| $170K | ﹤0.01% |
9,770
-13,518
| -58% | -$240K |
|
5085
Harvard Bioscience
HBIO
$28.7M
| $169K | ﹤0.01% |
3,993
-34
| -0.8% | -$1.53K |
|
|
KNTE
5086
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $168K | ﹤0.01% |
63,090
-93,136
| -60% | -$231K |
|
5087
DarioHealth
DRIO
$74.7M
| $166K | ﹤0.01% |
5,423
+157
| +3% | +$5.95K |
|
5088
FinWise Bancorp
FINW
$193M
| $165K | ﹤0.01% |
16,445
+5,134
| +45% | +$60K |
|
5089
Omeros
OMER
$916M
| $165K | ﹤0.01% |
47,853
+5,996
| +14% | +$22.8K |
|
5090
Century Therapeutics
IPSC
$353M
| $164K | ﹤0.01% |
39,283
-5,342
| -12% | -$22.6K |
|
5091
Black Stone Minerals
BSM
$3.09B
| $164K | ﹤0.01% |
10,268
-5,947
| -37% | -$94.2K |
|
5092
ProShares Trust Short MSCI EAFE
EFZ
$10.1M
| $163K | ﹤0.01% |
+5,010
| New | +$171K |
|
5093
Invesco Municipal Trust
VKQ
$544M
| $163K | ﹤0.01% |
16,836
+62
| +0.4% | +$591 |
|
5094
Prospect Capital
PSEC
$1.09B
| $163K | ﹤0.01% |
29,571
-33,553
| -53% | -$193K |
|
5095
BioAtla
BCAB
$5.52M
| $162K | ﹤0.01% |
944
+169
| +22% | +$21K |
|
5096
Blue Ridge Bankshares
BRBS
$330M
| $162K | ﹤0.01% |
60,206
+45,833
| +319% | +$125K |
|
5097
CVD Equipment Corp
CVV
$56.8M
| $162K | ﹤0.01% |
+34,329
| New | +$164K |
|
5098
Sagimet Biosciences
SGMT
$534M
| $161K | ﹤0.01% |
+29,746
| New | +$214K |
|
|
GATO
5099
DELISTED
Gatos Silver, Inc.
GATO
| $161K | ﹤0.01% |
+19,206
| New | +$128K |
|
5100
CALL
VF Corp
VFC
$5.98B
| $161K | ﹤0.01% |
+10,500
| New | +$169K |
|
Similar funds
Goldman Sachs's Q1 2024 Portfolio in Review
As of Q1 2024, Goldman Sachs held 6,050 positions worth $564B, up 4% from $543B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Goldman Sachs withdrew a net $23.2B in Q1 2024, closing 529 positions and reducing 2,527 holdings. Its most notable exit was Cooper Companies, an estimated $173M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Goldman Sachs opened a new position in State Street SPDR Portfolio Long Term Treasury ETF worth $195M.
- Goldman Sachs's largest Q1 2024 buy was State Street SPDR Portfolio Long Term Treasury ETF: 6,982,911 shares worth $195M.
- Goldman Sachs added most to iShares Core S&P 500 ETF in Q1 2024, an estimated $912M increase.
- Goldman Sachs's biggest Q1 2024 reduction was Microsoft, cutting an estimated $1.45B.
- Goldman Sachs fully exited Cooper Companies in Q1 2024, selling an estimated $173M.
- Goldman Sachs's ten largest holdings make up 19% of its $564B portfolio in Q1 2024.
- Goldman Sachs opened 470 new positions and closed 529 in Q1 2024.
- Goldman Sachs's portfolio value rose 4% quarter-over-quarter to $564B.
Based on Goldman Sachs's 13F filing for Q1 2024, filed 15 May 2024.